Experts at City of Hope, Simon Nazarian and Nasim Eftekhari, discussed the transformative potential of AI in cancer care.

Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.

CVS Health released a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from ...

Researchers of a new JAMA study said that without further participation in accountable care organizations, including the ACO REACH model, the program is unlikely to meet its goal of reducing health ...

A panelist discusses how preserving beta-cell function in type 1 diabetes (T1D) requires a multifaceted approach combining timely diagnosis, immunomodulatory therapies, optimal glycemic control and ...

Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, has joined. The National ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

In 2024, top issues included daily work activities, work-life balance and conflict with managers. Now in 2025, those concerns ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In a recent conversation with Managed Healthcare Executive, Geoffrey Rutledge, M.D., of HealthTap, warned that the narrative around GLP-1 drugs is often oversimplified—and potentially harmful.

In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., ...